Vasculitis and Giant Cell Arteritis

Top Story

Herpes zoster a 'potential trigger' for giant cell arteritis

Herpes zoster a 'potential trigger' for giant cell arteritis
December 13, 2017
FDA News

FDA expands approval of Nucala for eosinophilic granulomatosis with polyangiitis

December 12, 2017
The FDA has expanded the approved use of Nucala to treat adult patients with eosinophilic granulomatosis with polyangiitis, a rare autoimmune disease that causes…
Meeting News

Tailored, systematic rituximab regimens have similar relapse rates in ANCA-associated vasculitis

November 28, 2017
SAN DIEGO — In patients with ANCA-associated vasculitis, rituximab infusions customized to ANCA status do not appear to yield different relapse rates compared with…
Guest Editorial

Treatment of Giant Cell Arteritis With Tocilizumab: A Historical Perspective

Healio Rheumatology, November 2017
Gary S. Hoffman, MD, MS, MACR
I am thrilled to have Gary S. Hoffman, MD, MS, MACR, write this month’s Guest Editorial for Healio Rheumatology. No one, in my judgment, is better qualified to…
More Headlines »
CME CPE

Overcoming Barriers and Best Practices for Use of Biosimilars: Conversations Between Physicians and Pharmacists

This activity is supported by an educational grant from Pfizer, Inc.

As more biosimilars are approved for use in the United States, all members of the multidisciplinary care team will…
More »
Video
Meeting News

VIDEO: "Modest associations" found between baseline factors, steroid use

December 22, 2016
More »
Resource Centers
American College of Rheumatology Annual Meeting

American College of Rheumatology Annual Meeting

CME CE CE

Diagnosis and Treatment of Pemphigus Vulgaris: Strategies for Optimal Multidisciplinary Care

This activity is supported by an educational grant from Genentech, Inc.

This activity begins with a review of the presentation and diagnosis of pemphigus vulgaris, a rare but serious…
More »